-
CDC advisory committee recommends AstraZeneca + Sanofi's infant RSV immunization
A CDC advisory committee has unanimously recommended AstraZeneca and Sanofi's jointly developed RSV immunization for infants who are younger than 8 months, according to an Aug. 3 press release. -
Mark Cuban pharmacy's collaborations, partnerships
Mark Cuban Cost Plus Drug Co. has teamed up with numerous companies, including pharmacy benefit managers and independent pharmacies. -
GSK sues Pfizer over RSV shot
GSK filed a lawsuit against Pfizer on Aug. 2, claiming Pfizer's respiratory syncytial virus vaccine infringes on patents related to its own RSV shot. -
New York hospital's plan to 'unlock' hard-to-access drugs
The Brooklyn Hospital, based in New York City, is teaming up with Clearway Health to gain access to medications that regional hospitals can have difficulty obtaining. -
Compounding pharmacy CAPS recalls 13K bags of cardioplegia
Central Admixture Pharmacy Services, a nationwide compounding pharmacy business that sells to hospitals and outpatient facilities, voluntarily recalled more than 13,000 bags of cardioplegia because of sterility concerns. -
FDA outlines plan to boost supply of ADHD, binge-eating drugs
The FDA and Drug Enforcement Administration are calling on stakeholders throughout the pharmaceutical supply chain to do all they can to boost available quantities of stimulant medications for the treatment of ADHD, binge-eating and narcolepsy, according to an Aug. 1 joint statement. -
Acid poured on drug quality data: FDA reveals more on Intas violations
Months after the FDA reported multiple violations at an Intas Pharmaceuticals plant in India and blocked imports, the agency shared more details Aug. 1, including a report of an analyst pouring acid in a trash can filled with drug quality documents. -
Hospital pharmacy teams can't afford to fight with drugmakers, Ochsner leader says
The pharmacy team at New Orleans-based Ochsner Health is "pretty much begging" drug companies for critical drugs that are in short supply, according to Ryan Pepper, assistant vice president of pharmacy supply chain. -
Pfizer laying off 69 in Illinois
Pharmaceutical giant Pfizer is laying off 69 employees in Lake Forest, Illinois, according to WARN filings published July 25. -
Providence's new pharmacy offers national delivery, virtual services
Renton, Wash.-based Providence's pharmacy business, Credenda Health, opened its 22nd pharmacy in Portland, Ore. -
US to test Paxlovid as long COVID-19 therapy
The National Institutes of Health announced plans to test at least four different treatments for long COVID, including Pfizer’s Paxlovid, as potential therapies for the lasting condition, according to a July 31 news release. -
Biogen to buy rare disease drugmaker for $7.3B
Biogen has agreed to pay $7.3 billion to acquire Reata Pharmaceuticals — the maker of a new treatment for a rare genetic disorder. The deal is expected to close by the end of the year. -
All shortage-vulnerable Pfizer drugs are already in short supply
Of the 13 Pfizer essential drugs the United States Pharmacopeia named as the most likely to go into new or worsened shortages, all of them are already in short supply. -
Experts to CMS: Make Alzheimer's drug data public
More than two dozen physicians, public health researchers and health policy experts are urging the federal government to publicly share registry data on the safety and efficacy of the Alzheimer's drug Leqembi. -
UofL Health opens full-service pharmacy in underserved area
UofL Health's Mary & Elizabeth Hospital in Louisville, Ky., has opened its own full-service pharmacy, according to a July 27 news release. -
Phase 3 trial of postpartum depression med shows good results
A phase 3 trial of an oral drug called zuranolone significantly improved symptoms of postpartum depression in just 15 days. -
Indiana system opens $40M pharmacy hub
Indiana University Health, based in Indianapolis, recently unveiled its $40 million, 70,000-square-foot shared services pharmacy facility, according to a news release shared with Becker's. -
Kaiser Permanente mail-order pharmacy ranks No. 1 in customer satisfaction: JD Power
Kaiser Permanente Pharmacy ranked No. 1 for customer satisfaction among mail-order pharmacies in the J.D. Power 2023 U.S. Pharmacy Study. -
13 essential Pfizer drugs most vulnerable to shortages: USP
Thirteen essential drugs made at Pfizer's Rocky Mount, N.C., facility — which was recently damaged by a tornado — have a vulnerability score higher than 90 percent, according to a July 26 report from United States Pharmacopeia. -
ISMP updates list of look-alike drug names
The Institute for Safe Medical Practices has revised its list of look-alike drug names that are often confused, adding more than 80 drug pairs to the resource.
Page 48 of 50